Citations 1
Network Meta-Analysis Comparing Efficacy and Safety Outcomes of Atogepant, Rimegepant, and Galcanezumab in Patients with Episodic Migraine After Including CHALLENGE-MIG Trial (P9-12.007)
Gandhi, Pranav , Lalla, Anjana, McAllister, Peter , Bilchik, Tanya R., Rowe, David A. , Piron, Cristiano, Kelton, Kari , Ailani, Jessica , Lalla, Anjana, Nahas, Stephanie J. , Rowe, David, Singh, Rashmi B. Halker
Neurology | April 7, 2025 | Volume: 104 | Issue: 7_Supplement_1 | Pages: No page available
